The efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reports-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reports

Published:2020-08 Issue: Volume:52 Page:102107
ISSN:1876-2018
Container-title:Asian Journal of Psychiatry
language:en
Short-container-title:Asian Journal of Psychiatry

Author:

Wang Shikai,Guo Ping,Feng Min,Qian Mincai,Shen Xinhua,Wang Gang

Funder

This study support by National Science and Technology

eijing Municipal Science & Tech Commission (No.

uzhou Municipal Science and Tech Commission

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,General Psychology,General Medicine

Reference17 articles.

1. Antidepressant treatment of veterans with Parkinson’s disease and depression: analysis of a national sample;Chen;J. Geriatr. Psychiatry Neurol.,2007

2. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review;Drevets;Biol. Psychiatry,2013

3. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans;Ellis;Int. J. Neuropsychopharmacol.,2006

4. A practical approach to detection and treatment of depression in Parkinson disease and dementia;Goodarzi;Neurol. Clin. Pract.,2017

5. Scopolamine and depression: a role for muscarinic antagonism?;Hasselmann;CNS Neurol. Disord. Drug Targets,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP